Tumor delivery efficiency and apoptosis enhancement by EVO nanoparticles on murie hepatic carcinoma cell line H22

Journal of Biomedical Nanotechnology

Volumn 9, Issue 8, 2013, Pages 1354-1361

  Zhang, Quanan ^a,b   Liu, Qin ^c   Shen, Jie ^c   Chen, Huijuan ^b   Liu, Baorui ^a,c  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Apoptosis; Chemotherapy; Drug delivery; EVO nanoparticles; Hepatic carcinoma cells

Indexed keywords

ANTI-TUMOR EFFICACY; CHEMOTHERAPEUTIC AGENTS; FEASIBLE DESIGN; HEPATIC CARCINOMA; INTRAVENOUS ADMINISTRATION; NANOSCALE DELIVERY SYSTEMS; NANOSCALE PARTICLES; THERAPEUTIC EFFICIENCY;

CELL CULTURE; CELL DEATH; CHEMOTHERAPY; DRUG DELIVERY; DRUG PRODUCTS; NANOPARTICLES; POLYETHYLENE GLYCOLS;

TUMORS;

GELATINASE; MACROGOL; NANOPARTICLE; PEPTIDE; POLYCAPROLACTONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; IN VITRO STUDY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; TRANSMISSION ELECTRON MICROSCOPY;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BIOLOGICAL AVAILABILITY; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; EFFICIENCY; EVODIA; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED ICR; NANOPARTICLES; PLANT EXTRACTS; UP-REGULATION;

EID: 84880896915     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1631     Document Type: Article

References (48)

1. J. Jiang and C. Hu, Evodiamine: A novel anti-cancer alkaloid from Evodia rutaecarpa. Molecules 14, 1852 (2009).
2. C. H. Liao, S. L. Pan, J. H. Guh, Y. L. Chang, H. C. Pai, C. H. Lin, and C. M. Teng, Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis 26, 968 (2005).
3. X. Pan, J. M. Hartley, J. A. Hartley, K. N. White, Z. Wang, and S. W. Bligh, Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells. Phytomedicine 19, 618 (2012).
4. X. F. Fei, B. X. Wang, T. J. Li, S. Tashiro, M. Minami, D. J. Xing, and T. Ikejima, Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells. Cancer Sci. 94, 92 (2003).
5. T. J. Lee, E. J. Kim, S. Kim, E. M. Jung, J. W. Park, S. H. Jeong, S. E. Park, Y. H. Yoo, and T. K. Kwon, Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol. Cancer Ther. 5, 2398 (2006).
6. Y. Takada, Y. Kobayashi, and B. B. Aggarwal, Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J. Biol. Chem. 280, 17203 (2005).
7. S. F. Kan, W. J. Huang, L. C. Lin, and P. S. Wang, Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Int. J. Cancer 110, 641 (2004).
8. B. Koppolu, Z. Bhavsar, A. S. Wadajkar, S. Nattama, M. Rahimi, F. Nwariaku, and K. T. Nguyen, Temperature-sensitive polymer-coated magnetic nanoparticles as a potential drug delivery system for targeted therapy of thyroid cancery. J. Biomed. Nanotechnol. 8, 983 (2012).
9. J. Lalani, Y. Raichandani, R. Mathur, M. Lalan, K. Chutani, A. K. Mishra, and A. Misra, Comparative receptor based brain delivery of tramadol-loaded poly(lactic-co-glycolic acid) nanoparticles. J. Biomed. Nanotechnol. 8, 918 (2012).
10. P. Sahdev, S. Podaralla, R. S. Kaushik, and O. Perumal, Calcium phosphate nanoparticles for transcutaneous vaccine delivery. J. Biomed. Nanotechnol. 9, 132 (2013).
11. M. S. Khan, G. D. Vishakante, and A. Bathool, Development and characterization of pilocarpine loaded eudragit nanosuspensions for ocular drug delivery. J. Biomed. Nanotechnol. 9, 124 (2013).
12. Z. F. Wang, L. Jia, and M. H. Li, Gold nanoparticles decorated by amphiphilic block copolymer as efficient system for drug delivery. J. Biomed. Nanotechnol. 9, 61 (2013).
13. A. O. Kamel and A. A. Mahmoud, Enhancement of human oral bioavailability and in vitro antitumor activity of rosuvastatin via spray dried self-nanoemulsifying drug delivery system. J. Biomed. Nanotechnol. 9, 26 (2013).
14. A. Babu, K. Jeyasubramanian, P. Gunasekaran, and R. Murugesan, Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model. J. Biomed. Nanotechnol. 8, 43 (2012).
15. E. Pedziwiatr-Werbicka, D. Shcharbin, J. Maly, M. Maly, M. Zaborski, B. Gabara, P. Ortega, F. J. Mata, R. Gómez, M. A. Muñoz-Fernandez, B. Klajnert, and M. Bryszewska, Carbosilane dendrimers are a non-viral delivery system for antisense oligonucleotides: characterization of dendriplexes. J. Biomed. Nanotechnol. 8, 57 (2012).
16. B. X. Xue, Y. J. Wang, X. H. Tang, P. Xie, Y. J. Wang, F. Luo, C. J. Wu, and Z. Y. Qian, Biodegradable self-assembled MPEGPCL micelles for hydrophobic oridonin delivery in vitro. J. Biomed. Nanotechnol. 8, 80 (2012).
17. Q. Y. Zhang, N. He, L. Zhang, F. Zhu, Q. X. Chen, Y. Qin, Z. R. Zhang, Q. Zhang, S. Wang, and Q. He, The in vitro and in vivo study on self-nanoemulsifying drug delivery system (SNEDDS) based on insulin-phospholipid complex. J. Biomed. Nanotechnol. 8, 90 (2012).
18. D. Wehrung and M. O. Oyewumi, Antitumor effect of novel gallium compounds and efficacy of nanoparticle-mediated gallium delivery in lung cancer. J. Biomed. Nanotechnol. 8, 161 (2012).
19. R. Bakhshi, Z. Ahmad, M. Soric, E. Stride, and M. Edirisinghe, Nanoparticle delivery systems formed using electrically sprayed coflowing excipients and active agent. J. Biomed. Nanotechnol. 7, 782 (2011).
20. G. D. Venkatasubbu, S. Ramasamy, V. Ramakrishnan, and J. Kumar, Hydroxyapatite-alginate nanocomposite as drug delivery matrix for sustained release of ciprofloxacin. J. Biomed. Nanotechnol. 7, 759 (2011).
21. A. Taheri, R. Dinarvand, F. Atyabi, F. Nouri, F. Ahadi, M. H. Ghahremani, S. N. Ostad, A. T. Borougeni, and P. Mansoori, Targeted delivery of methotrexate to tumor cells using biotin functionalized methotrexate-human serum albumin conjugated nanoparticles. J. Biomed. Nanotechnol. 7, 743 (2011).
22. G. Thirumurugan, V. S. Veni, S. Ramachandran, J. V. L. N. S. Rao, and M. D. Dhanaraju, Superior wound healing effect of topically delivered silver nanoparticle formulation using eco-friendly potato plant pathogenic fungus: synthesis and characterization. J. Biomed. Nanotechnol. 7, 659 (2011).
23. J. Wang, H. N. Tan, A. H. Yu, P. X. Ling, H. X. Lou, G. X. Zhai, and J. Wu, Preparation of chitosan-based nanoparticles for delivery of low molecular weight heparin. J. Biomed. Nanotechnol. 7, 696 (2011).
24. L. L. Li, Y. D. Zhang, S. W. Han, Z. Qu, J. F. Zhao, Y. X. Chen, Z. C. Chen, J. H. Duan, Y. F. Pan, and X. H. Tang, Penetration enhancement of lidocaine hydrochlorid by a novel chitosan coated elastic liposome for transdermal drug delivery. J. Biomed. Nanotechnol. 7, 704 (2011).
25. S. Nimesh, N. Gupta, and R. Chandra, Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids. J. Biomed. Nanotechnol. 7, 504 (2011).
26. N. S. Rejinold, M. Muthunarayanan, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, Curcumin loaded fibrinogen nanoparticles for cancer drug delivery. J. Biomed. Nanotechnol. 7, 521 (2011).
27. P. Soman, W. D. Zhang, A. Umeda, Z. W. J. Zhang, and S. C. Chen, Femtosecond laser-assisted optoporation for drug and gene delivery into single mammalian cells. J. Biomed. Nanotechnol. 7, 334 (2011).
28. M. C. Terence, S. B. Faldini, L. F. Miranda, A. H. M. Júnior, and P. J. Castro, Preparation and characterization of a polymeric blend of PVP/PVAL for use in drug delivery system. J. Biomed. Nanotechnol. 7, 446 (2011).
29. D. D. Ankola, R. M. Wadsworth, and M. N. V. R. Kumar, Nanoparticulate delivery can improve peroral bioavailability of cyclosporine and match neoral cmax sparing the kidney from damage. J. Biomed. Nanotechnol. 7, 300 (2011).
30. R. Goyal, S. K. Tripathi, S. Tyagi, K. R. Ram, K. M. Ansari, P. Kumar, Y. Shukla, D. Kar Chowdhuri, and K. C. Gupta, Gellan gum-PEI nanocomposites as efficient gene delivery agents. J. Biomed. Nanotechnol. 7, 38 (2011).
31. V. Pokharkar, D. Bhumkar, K. Suresh, Y. Shinde, S. Gairola, and S. S. Jadhav, Gold nanoparticles as a potential carrier for transmucosal vaccine delivery. J. Biomed. Nanotechnol. 7, 57 (2011).
32. A. K. Verma, R. P. Pandey, A. Chanchal, and P. Sharma, Immunopotentiating role of encapsulated proteins of infectious diseases in biopolymeric nanoparticles as a potential delivery system. J. Biomed. Nanotechnol. 7, 63 (2011).
33. S. Rai, R. Paliwal, and S. P. Vyas, Doxorubicin encapsulated nanocarriers for targeted delivery to estrogen responsive breast cancer. J. Biomed. Nanotechnol. 7, 121 (2011).
34. R. Paliwal, S. Rai, and S. P. Vyas, Lipid drug conjugate (LDC) nanoparticles as autolymphotrophs for oral delivery of methotrexate. J. Biomed. Nanotechnol. 7, 130 (2011).
35. S. Malathi and S. Balasubramanian, Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis. J. Biomed. Nanotechnol. 7, 150 (2011).
36. J. Fu, D. X. Wang, T. Wang, W. J. Yang, Y. Deng, H. Wang, S. G. Jin, and N. Y. He, High entrapment efficiency of chitosan/polylactic acid/ tripolyphotspate nanosized microcapsules for rapamycin by an emulsion-evaporation approach. J. Biomed. Nanotechnol. 6, 725 (2010).
37. W. J. Yang, J. Fu, T. Wang, and N. Y. He, Chitosan/sodium tripolyphosphate nanoparticles: Preparation, characterization and application as drug carrier. J. Biomed. Nanotechnol. 5, 591 (2009).
38. O. C. Farokhzad, J. Cheng, B. A. Teply, I. Sherifi, S. Jon, P. W. Kantoff, J. P. Richie, and R. Langer, Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc. Natl. Acad. Sci. USA 103, 6315 (2006).
39. Z. Liu, W. Cai, L. He, N. Nakayama, K. Chen, X. M. Sun, X. Y. Chen, and H. J. Dai, In vivo biodistribution and highly efficient tumour targeting of carbonnanotubes in mice. Nat. Nanotechnol. 2, 47 (2007).
40. L. Y. Li, C. A. Wartchow, S. N. Danthi, Z. Shen, N. Dechene, J. Pease, H. S. Choi, T. Doede, P. Chu, S. Ning, D. Y. Lee, M. D. Bednarski, and S. J. Knox, A novel antiangiogenesis therapy using an integrin antagonist or anti-FLK-1 antibody coated Y-90-labeled nanoparticles. Int. J. Radiat. Oncol. 58, 1215 (2004).
41. M. E. Werner, S. Karve, R. Sukumar, N. D. Cummings, J. A. Copp, R. C. Chen, T. Zhang, and A. Z. Wang, Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis. Biomaterials 32, 8548 (2011).
42. W. Y. Tai, R. Mahato, and K. Cheng, The role of HER2 in cancer therapy and targeted drug delivery. J. Control. Release 146, 264 (2010).
43. S. Dai, P. Ravi, and K. C. Tam, Thermo- and photo-responsive polymeric systems. Soft Matter. 5, 2513 (2009).
44. B. Chen, J. Cheng, Y. Wu, F. Gao, W. Xu, H. Shen, J. Ding, C. Gao, Q. Sun, X. Sun, H. Cheng, G. Li, W. Chen, N. Chen, L. Liu, X. Li, and X. Wang, Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice. Int. J. Nanomedicine 4, 73 (2009).
45. T. Konno, H. Hasuda, K. Ishihara, and Y. Ito, Photo-immobilization of a phospholipid polymer for surface modifcation. Biomaterials 26, 1381 (2005).
46. F. Danhier, O. Feron, and V. Preat, To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control. Release 148, 135 (2010).
47. P. S. Steeg and D. Theodorescu, Metastasis: a therapeutic target for cancer. Nat. Clin. Pract. Oncol. 5, 206 (2008).
48. Q. Liu, R. T. Li, H. Q. Qian, M. Yang, Z. S. Zhu, W. Wu, X. P. Qian, L. X. Yu, X. Q. Jiang, and B. R. Liu, Gelatinasestimuli strategy enhances the tumor delivery and therapeutic efficacy of docetaxel-loaded poly (ethylene glycol)-poly(varepsiloncaprolactone) nanoparticles. Int. J. Nanomedicine 7, 281 (2012).